Want to see JP:9218 full AI Analyst Report?
Top Page
Mental Health Technologies Co. Ltd.
(9218)
Select Model
Select Model
Rating:58Neutral
Price Target:
¥777.00
▼(-5.24% Downside)
Action:Reiterated
Date:08/06/26
The score is driven primarily by improving financial momentum and cash flow in 2025, but held back by meaningfully compressed margins and elevated leverage. Technical signals are moderately positive, while valuation is less supportive due to a high P/E and only modest dividend yield.
Positive Factors
Improving Revenue Momentum
The return to stronger revenue growth indicates improving business momentum after modest expansion in 2024. Sustained top-line progress can support operating leverage, customer scale and investment capacity over the next several quarters.
Negative Factors
Structural Margin Compression
The sharp decline in gross margin and thin net margin leave limited room for execution errors, cost increases or weaker demand. Unless margins recover, revenue growth may translate into only modest earnings and cash-flow improvement.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving Revenue Momentum
The return to stronger revenue growth indicates improving business momentum after modest expansion in 2024. Sustained top-line progress can support operating leverage, customer scale and investment capacity over the next several quarters.
Read all positive factors
Mental Health Technologies Co. Ltd. (9218) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥8.30B
Dividend Yield1.29%
Average Volume (3M)17.05K
Price to Earnings (P/E)34.1
Beta (1Y)0.59
Revenue Growth27.65%
EPS Growth-28.38%
CountryJP
Employees140
SectorGeneral
Sector StrengthN/A
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)22.99
Shares Outstanding10,507,300
10 Day Avg. Volume21,630
30 Day Avg. Volume17,046
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)5.43
Price to Sales (P/S)1.32
P/FCF Ratio15.25
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)28.6
Revenue Forecast (FY)¥9.20B
Mental Health Technologies Co. Ltd. Business Overview & Revenue Model
Company Description
Operating in Japan, Mental Health Technologies Co.,Ltd. offers a diverse portfolio of services, encompassing mental wellness solutions, career development assistance for medical professionals, and digital advertising. The company additionally mana...
How the Company Makes Money
null...
Mental Health Technologies Co. Ltd. Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
44
Neutral
Cash Flow
66
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.73B | 6.44B | 5.13B | 2.61B | 2.29B | 1.45B |
| Gross Profit | 2.07B | 2.03B | 1.76B | 1.42B | 1.40B | 745.80M |
| EBITDA | 790.05M | 661.94M | 257.58M | 534.92M | 396.89M | 163.06M |
| Net Income | 239.32M | 254.90M | -29.78M | 441.37M | 265.12M | 161.83M |
Balance Sheet | ||||||
| Total Assets | 5.80B | 5.37B | 4.63B | 1.73B | 1.30B | 663.62M |
| Cash, Cash Equivalents and Short-Term Investments | 1.13B | 1.49B | 1.12B | 913.71M | 659.51M | 423.50M |
| Total Debt | 3.07B | 2.62B | 2.57B | 332.49M | 183.77M | 188.52M |
| Total Liabilities | 4.28B | 3.80B | 3.33B | 618.32M | 640.75M | 416.20M |
| Stockholders Equity | 1.53B | 1.57B | 1.29B | 1.12B | 655.37M | 247.42M |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 558.09M | 318.71M | 146.70M | 364.78M | 199.36M |
| Operating Cash Flow | 0.00 | 631.99M | 345.90M | 177.54M | 377.49M | 202.14M |
| Investing Cash Flow | 0.00 | -324.30M | -2.15B | -90.61M | -260.33M | -20.79M |
| Financing Cash Flow | 0.00 | 67.82M | 2.00B | 167.28M | 118.85M | 53.33M |
Mental Health Technologies Co. Ltd. Technical Analysis
Positive
820.00
Price Trends
744.30
Positive
730.70
Positive
763.31
Positive
Market Momentum
13.66
Negative
67.83
Neutral
93.69
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9218, the sentiment is Positive. The current price of 820 is above the 20-day moving average (MA) of 765.35, above the 50-day MA of 744.30, and above the 200-day MA of 763.31, indicating a bullish trend. The MACD of 13.66 indicates Negative momentum. The RSI at 67.83 is Neutral, neither overbought nor oversold. The STOCH value of 93.69 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:9218.
Mental Health Technologies Co. Ltd. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥1.24T | 25.95 | 11.45% | 1.16% | 15.76% | 13.53% | |
59 Neutral | ¥83.24B | 43.08 | 12.35% | ― | 24.03% | 34.50% | |
58 Neutral | ¥8.30B | 34.13 | ― | ― | 27.65% | -28.38% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
45 Neutral | ¥2.18B | -4.15 | ― | ― | 14.84% | 30.67% | |
44 Neutral | ¥7.52B | -19.42 | ― | ― | 7.39% | -27.75% |
* General Sector Average
JP:9218
Mental Health Technologies Co. Ltd.
776.00
-13.87
-1.76%
JP:2413
M3
1,782.50
-453.23
-20.27%
JP:4480
Medley
2,590.00
148.00
6.06%
JP:4263
SUSMED,Inc.
441.00
-482.00
-52.22%
JP:4438
Welby Inc.
259.00
-71.00
-21.52%
JP:366A
Wellness Communications Corporation
1,160.00
-326.53
-21.97%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.